The aim of our study was to evaluate the in vitro sensitivity of human CCA primary cell cultures, prepared from mucin- and mixed-CCA, to chemotherapeutics and molecular targeted agents. The gene discussed is MUC5AC; the disease is cholangiocarcinoma.